Income Statement Eurobio Scientific

Stocks

ALERS

FR0013240934

Biotechnology & Medical Research

Real-time Euronext Paris Other stock markets 11:16:09 2026-06-11 am EDT			5-day change	1st Jan Change
22.20 ^EUR	-3.06%		-0.89%	-8.83%

Apr. 20	CareDx Inc Introduces AlloSeq Nano Expanding HLA Typing Portfolio With Long-Read Sequencing	CI
Apr. 16	Eurobio Scientific to Buy CareDx's Lab Products Division for EUR145 Million	MT

be03e216dcb69ef64f181510c70a.-0BwP61ZlTkXuUTq-QPiATTykvtOhzv0X-GeZJvziEg.nzY3dddt_FUggSOGrWXXZ2ODpIEstEOgEYbkUu6J5XykOBZymjumaWTKHQ

Published financial data: EUROBIO SCIENTIFIC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	185M	153M	131M	155M	169M
Other Revenues, Total	-	-	-	-1K	-
Total Revenues	185M	153M	131M	155M	169M
Cost of Goods Sold, Total	85.91M	85.13M	73.16M	82.99M	91.75M
Gross Profit	99.41M	67.77M	57.49M	71.95M	76.84M
Selling General & Admin Expenses, Total	24.5M	31M	33.52M	38.86M	52.99M
R&D Expenses	-	-	5.9M	4.64M	-
Amortization of Goodwill and Intangible Assets - (IS)	4.79M	5.9M	7.92M	8.52M	3.78M
Other Operating Expenses	-	-	-	-	9.33M
Other Operating Expenses, Total	29.29M	36.9M	47.35M	52.02M	66.1M
Operating Income	70.12M	30.87M	10.14M	19.93M	10.74M
Interest Expense, Total	-412K	-1.26M	-4.36M	-4.12M	-1.94M
Interest And Investment Income	-	43K	1.12M	1.48M	28K
Net Interest Expenses	-412K	-1.22M	-3.24M	-2.65M	-1.91M
Currency Exchange Gains (Loss)	355K	666K	748K	687K	-1.04M
Other Non Operating Income (Expenses)	-50K	36K	774K	-3.71M	191K
EBT, Excl. Unusual Items	70.01M	30.35M	8.42M	14.26M	7.98M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-6.6M	-
Gain (Loss) On Sale Of Investments	227K	-	-	-	-174K
Other Unusual Items	1.08M	-669K	-1.45M	-1.38M	-
EBT, Incl. Unusual Items	71.31M	29.68M	6.98M	6.28M	7.8M
Income Tax Expense	10.77M	4.75M	2.14M	2.29M	2.94M
Earnings From Continuing Operations	60.54M	24.94M	4.84M	4M	4.86M
Net Income to Company	60.54M	24.94M	4.84M	4M	4.86M
Minority Interest	-	-	-	-	-
Net Income - (IS)	60.54M	24.94M	4.84M	4M	4.86M
Net Income to Common Incl Extra Items	60.54M	24.94M	4.84M	4M	4.86M
Net Income to Common Excl. Extra Items	60.54M	24.94M	4.84M	4M	4.86M
Per Share Items
Net EPS - Basic	5.58	2.44	0.43	0.39	0.47
Basic EPS - Continuing Operations	5.58	2.44	0.43	0.39	0.47
Basic Weighted Average Shares Outstanding	10.85M	10.22M	11.15M	10.26M	10.25M
Net EPS - Diluted	5.57	2.43	0.43	0.39	0.47
Diluted EPS - Continuing Operations	5.57	2.43	0.43	0.39	0.47
Diluted Weighted Average Shares Outstanding	10.88M	10.26M	11.22M	10.26M	10.25M
Normalized Basic EPS	4.03	1.86	0.47	0.87	0.49
Normalized Diluted EPS	4.02	1.85	0.47	0.87	0.49
Supplemental Items
EBITDA	77.6M	39.07M	18.99M	29.44M	22.44M
EBITA	74.61M	35.46M	14.75M	24.6M	16.84M
EBIT	70.12M	30.87M	10.14M	19.93M	10.74M
Total Revenues (As Reported)	185M	153M	131M	155M	-
Effective Tax Rate - (Ratio)	15.1	15.99	30.7	36.38	37.67
Total Current Taxes	9.13M	3.43M	3.9M	4.65M	3.87M
Total Deferred Taxes	1.64M	1.32M	-1.76M	-2.36M	-928K
Normalized Net Income	43.76M	18.97M	5.26M	8.91M	4.99M
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	-59K	-159K	100K	75K	-74K
Supplemental Operating Expense Items
Selling and Marketing Expenses	17.08M	19.6M	19.25M	23.68M	34.26M
General and Administrative Expenses	7.42M	11.4M	14.27M	15.18M	18.73M
Research And Development Expense From Footnotes	3.82M	4.48M	8.56M	7.55M	7.88M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	92.92M	47.49M	49.3M	21.77M	20.32M
Short Term Investments	9.47M	38.44M	39.73M	1.29M	348K
Total Cash And Short Term Investments	102M	85.94M	89.03M	23.06M	20.66M
Accounts Receivable, Total	43.86M	32.78M	26.94M	32.09M	33.02M
Other Receivables	8.96M	6.09M	3.74M	3.97M	3.54M
Total Receivables	52.82M	38.87M	30.67M	36.06M	36.56M
Inventory	16.29M	21.65M	21.45M	26.92M	28.63M
Prepaid Expenses	472K	572K	1.01M	1.31M	2.34M
Deferred Tax Assets Current	-	125K	357K	1.06M	1.28M
Other Current Assets, Total	1.62M	1.53M	1.39M	1.18M	2.11M
Total Current Assets	174M	149M	144M	89.59M	91.58M
Gross Property Plant And Equipment	23M	28.18M	34.73M	41.24M	44.93M
Accumulated Depreciation	-12.96M	-15.52M	-22.43M	-28.47M	-32.3M
Net Property Plant And Equipment	10.05M	12.66M	12.3M	12.77M	12.63M
Long-term Investments	3.6M	3.6M	3.6M	100K	100K
Goodwill	18.19M	116M	118M	119M	123M
Other Intangibles, Total	2.29M	1.97M	2.52M	2.1M	1.12M
Loans Receivable Long-Term	861K	10.8M	3.39M	1.2M	954K
Deferred Tax Assets Long-Term	-	-	-	-	-
Deferred Charges Long-Term	1.28M	37.2M	32.9M	32.52M	27.63M
Other Long-Term Assets, Total	1K	-	-	1K	1K
Total Assets	210M	331M	316M	257M	257M
Liabilities
Accounts Payable, Total	16.77M	18.53M	16.82M	19.02M	20.87M
Accrued Expenses, Total	8.69M	9.63M	6.07M	6.15M	5.62M
Current Portion of Long-Term Debt	3.68M	13.73M	13.28M	725K	-
Current Portion of Leases	1.56M	1.6M	1.8M	2.07M	-
Current Income Taxes Payable	4.16M	1.97M	3.56M	5.48M	5.5M
Unearned Revenue Current, Total	155K	438K	201K	180K	304K
Deferred Tax Liability Current	-	10.17M	8.51M	7.77M	-
Other Current Liabilities	1.1M	1.25M	2.64M	2.76M	2.47M
Total Current Liabilities	36.11M	57.32M	52.88M	44.15M	34.76M
Long-Term Debt	7.01M	94.34M	81.23M	2.86M	10.12M
Long-Term Leases	3.44M	3.97M	4.35M	4.12M	5.88M
Pension & Other Post Retirement Benefits	753K	594K	528K	604K	524K
Deferred Tax Liability Non Current	-	-	-	-	7.13M
Other Non Current Liabilities	1.69M	1.53M	2.17M	26.59M	14.42M
Total Liabilities	49M	158M	141M	78.31M	72.83M
Common Stock, Total	3.63M	3.63M	3.5M	3.28M	3.28M
Additional Paid In Capital	40.05M	40.05M	33.57M	20.19M	20.19M
Comprehensive Income and Other	117M	129M	138M	155M	160M
Total Common Equity	161M	173M	175M	179M	184M
Minority Interest	-	-	-	-	-
Total Equity	161M	173M	175M	179M	184M
Total Liabilities And Equity	210M	331M	316M	257M	257M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10.85M	10.22M	10.04M	10.03M	10.07M
ECS Total Common Shares Outstanding	10.85M	10.22M	10.04M	10.03M	10.07M
Book Value / Share	14.83	16.92	17.44	17.82	18.27
Tangible Book Value	140M	55.2M	54.94M	57.86M	60.06M
Tangible Book Value Per Share	12.94	5.4	5.47	5.77	5.97
Total Debt	15.69M	114M	101M	9.77M	16M
Net Debt	-86.7M	27.7M	11.63M	-13.3M	-4.66M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	17.27M	26.65M	23.73M	28.82M	30.67M
Inventories - Others	831K	857K	1.84M	3.61M	3.44M
Buildings, Total	852K	883K	1.33M	1.82M	1.86M
Machinery, Total	9.39M	1.12M	757K	1.09M	1.33M
Full Time Employees	169	286	300	326	343
Assets under Capital Lease - Gross	9.71M	9.19M	10.04M	11.88M	13.71M
Assets under Capital Lease - Accumulated Depreciation	-4.66M	-3.66M	-3.89M	-5.78M	-7.97M
Accumulated Allowance for Doubtful Accounts (Supple)	1.46M	1.48M	1.07M	998K	645K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	60.54M	24.94M	4.84M	4M	4.86M
Depreciation & Amortization - CF	2.99M	3.62M	4.24M	4.85M	5.59M
Amortization of Goodwill and Intangible Assets - (CF)	4.5M	4.58M	4.61M	4.67M	6.1M
Depreciation & Amortization, Total	7.48M	8.2M	8.84M	9.51M	11.7M
Amortization of Deferred Charges, Total - (CF)	380K	1.43M	4.3M	4.55M	4.9M
(Gain) Loss From Sale Of Asset	-	-1.77M	55K	68K	309K
Other Operating Activities, Total	1.17M	1.43M	387K	2.88M	1.33M
Change In Accounts Receivable	2.05M	20.84M	12.9M	-2.84M	-3.23M
Change In Inventories	-3.3M	238K	2.04M	-3.84M	-1.92M
Change In Accounts Payable	-	-	-	-	735K
Change in Unearned Revenues	-25K	284K	-237K	-80K	124K
Change in Other Net Operating Assets	-2.39M	-12.52M	-6.35M	2.46M	52K
Cash from Operations	65.92M	43.07M	26.77M	16.7M	18.85M
Capital Expenditure	-1.85M	-2.83M	-4.05M	-3.26M	-12.57M
Sale of Property, Plant, and Equipment	100K	2.52M	1.9M	169K	18K
Cash Acquisitions	-	-132M	-4.5M	-10.12M	-593K
Investment in Marketable and Equity Securities, Total	-3.72M	-9.28M	6.34M	2.47M	250K
Other Investing Activities, Total	1K	-	-	-1K	-
Cash from Investing	-5.47M	-142M	-318K	-10.74M	-12.89M
Short Term Debt Issued, Total	-	-	-	23.45M	-
Long-Term Debt Issued, Total	-	105M	-	-	8M
Total Debt Issued	-	105M	-	23.45M	8M
Short Term Debt Repaid, Total	-	-	-	-	-10.86M
Long-Term Debt Repaid, Total	-15.96M	-9.25M	-18.2M	-92.72M	-3.59M
Total Debt Repaid	-15.96M	-9.25M	-18.2M	-92.72M	-14.44M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-6.91M	-12.24M	-2.79M	-149K	-
Other Financing Activities, Total	-882K	-1.21M	-2.51M	-2.66M	-1.72M
Cash from Financing	-23.76M	82.31M	-23.5M	-72.09M	-8.16M
Foreign Exchange Rate Adjustments	138K	-77K	147K	159K	-202K
Miscellaneous Cash Flow Adjustments	-	-	-	1K	1K
Net Change in Cash	36.83M	-16.45M	3.09M	-65.96M	-2.4M
Supplemental Items
Cash Interest Paid	455K	1.22M	2.47M	2.66M	1.72M
Levered Free Cash Flow	46.34M	44.88M	16.39M	12.59M	6.3M
Unlevered Free Cash Flow	46.6M	45.67M	19.11M	15.17M	7.51M
Change In Net Working Capital	3.24M	-19.58M	-3.68M	8.09M	3.22M
Net Debt Issued / Repaid	-15.96M	95.75M	-18.2M	-69.27M	-6.44M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	22.93	7.14	1.96	4.34	2.61
Return on Total Capital	27.9	8.33	2.25	5.36	3.46
Return On Equity %	45.06	14.94	2.78	2.26	2.68
Return on Common Equity	45.06	14.94	2.78	2.26	2.68
Margin Analysis
Gross Profit Margin %	53.64	44.33	44	46.44	45.58
SG&A Margin	13.22	20.27	25.66	25.08	31.43
EBITDA Margin %	41.87	25.55	14.53	19	13.31
EBITA Margin %	40.26	23.19	11.29	15.88	9.99
EBIT Margin %	37.84	20.19	7.76	12.86	6.37
Income From Continuing Operations Margin %	32.67	16.31	3.7	2.58	2.89
Net Income Margin %	32.67	16.31	3.7	2.58	2.89
Net Avail. For Common Margin %	32.67	16.31	3.7	2.58	2.89
Normalized Net Income Margin	23.61	12.41	4.03	5.75	2.96
Levered Free Cash Flow Margin	25.01	29.35	12.54	8.13	3.74
Unlevered Free Cash Flow Margin	25.15	29.87	14.63	9.79	4.46
Asset Turnover
Asset Turnover	0.97	0.57	0.4	0.54	0.66
Fixed Assets Turnover	18.56	13.46	10.47	12.36	13.28
Receivables Turnover (Average Receivables)	3.9	3.99	4.38	5.25	5.18
Inventory Turnover (Average Inventory)	5.88	4.49	3.39	3.43	3.3
Short Term Liquidity
Current Ratio	4.81	2.59	2.72	2.03	2.63
Quick Ratio	4.3	2.18	2.26	1.34	1.65
Operating Cash Flow to Current Liabilities	1.83	0.75	0.51	0.38	0.54
Days Sales Outstanding (Average Receivables)	93.63	91.48	83.42	69.71	70.47
Days Outstanding Inventory (Average Inventory)	62.07	81.35	107.52	106.65	110.49
Average Days Payable Outstanding	63.38	71.19	88.42	74.12	77.88
Cash Conversion Cycle (Average Days)	92.31	101.64	102.52	102.24	103.08
Long Term Solvency
Total Debt/Equity	9.75	65.69	57.46	5.46	8.7
Total Debt / Total Capital	8.89	39.65	36.49	5.18	8
LT Debt/Equity	6.49	56.83	48.86	3.9	8.7
Long-Term Debt / Total Capital	5.92	34.3	31.03	3.7	8
Total Liabilities / Total Assets	23.35	47.7	44.62	30.45	28.37
EBIT / Interest Expense	170.19	24.44	2.33	4.83	5.55
EBITDA / Interest Expense	188.35	30.94	4.36	7.14	11.58
(EBITDA - Capex) / Interest Expense	183.87	28.69	3.43	6.35	5.09
Total Debt / EBITDA	0.2	2.91	5.3	0.33	0.71
Net Debt / EBITDA	-1.12	0.71	0.61	-0.45	-0.21
Total Debt / (EBITDA - Capex)	0.21	3.14	6.74	0.37	1.62
Net Debt / (EBITDA - Capex)	-1.14	0.76	0.78	-0.51	-0.47
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.04	-17.49	-14.55	18.6	9.08
Gross Profit, 1 Yr. Growth %	-8.39	-31.82	-19.3	25.16	7.37
EBITDA, 1 Yr. Growth %	-12.04	-49.9	-53.12	26.45	-18.09
EBITA, 1 Yr. Growth %	-13.35	-52.72	-60	29.12	-25.29
EBIT, 1 Yr. Growth %	-13.66	-55.97	-67.15	96.55	-19.43
Earnings From Cont. Operations, 1 Yr. Growth %	-17.61	-58.81	-80.61	-17.31	21.69
Net Income, 1 Yr. Growth %	-17.61	-58.81	-80.61	-17.31	21.69
Normalized Net Income, 1 Yr. Growth %	-13.42	-56.65	-72.25	69.33	4.12
Diluted EPS Before Extra, 1 Yr. Growth %	-14.7	-56.37	-80.44	-9.42	20.51
Accounts Receivable, 1 Yr. Growth %	-14.35	-25.26	-17.82	19.12	2.9
Inventory, 1 Yr. Growth %	26.03	32.91	-0.95	25.49	6.37
Net Property, Plant and Equip., 1 Yr. Growth %	1.3	26.05	-2.88	3.8	-1.06
Total Assets, 1 Yr. Growth %	21.8	57.59	-4.35	-18.7	-0.16
Tangible Book Value, 1 Yr. Growth %	68.99	-60.68	-0.48	5.31	3.81
Common Equity, 1 Yr. Growth %	49.16	7.53	1.27	2.1	2.83
Cash From Operations, 1 Yr. Growth %	20	-34.65	-37.86	-37.6	12.87
Capital Expenditures, 1 Yr. Growth %	-19.59	53.44	43.05	-19.68	286.03
Levered Free Cash Flow, 1 Yr. Growth %	69.35	-3.16	-63.49	-23.14	796.18
Unlevered Free Cash Flow, 1 Yr. Growth %	67.97	-2	-58.16	-20.6	128.98
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	76.52	-10.1	-16.04	0.67	13.6
Gross Profit, 2 Yr. CAGR %	132.78	-20.97	-23.95	0.5	15.62
EBITDA, 2 Yr. CAGR %	234.44	-33.45	-50.66	-14.73	-1.84
EBITA, 2 Yr. CAGR %	267.55	-35.83	-55.65	-18.33	-5.97
EBIT, 2 Yr. CAGR %	1.01K	-38.35	-61.97	-19.65	2.92
Earnings From Cont. Operations, 2 Yr. CAGR %	338.2	-41.74	-71.74	-59.96	0.31
Net Income, 2 Yr. CAGR %	338.2	-41.74	-71.74	-59.96	0.31
Normalized Net Income, 2 Yr. CAGR %	937.82	-38.73	-65.31	-31.45	-2.67
Diluted EPS Before Extra, 2 Yr. CAGR %	346.01	-39	-72.22	-57.91	4.55
Accounts Receivable, 2 Yr. CAGR %	53.4	-19.99	-21.63	-1.06	10.71
Inventory, 2 Yr. CAGR %	35.34	29.43	14.74	11.49	15.54
Net Property, Plant and Equip., 2 Yr. CAGR %	13.9	13	10.64	0.4	1.34
Total Assets, 2 Yr. CAGR %	60.96	38.55	22.77	-11.82	-9.91
Tangible Book Value, 2 Yr. CAGR %	314.71	-18.48	-37.44	2.37	4.56
Common Equity, 2 Yr. CAGR %	109.75	26.65	4.35	1.68	2.47
Cash From Operations, 2 Yr. CAGR %	263.45	-11.45	-36.28	-37.73	-16.08
Capital Expenditures, 2 Yr. CAGR %	7.71	11.08	48.15	7.19	76.08
Levered Free Cash Flow, 2 Yr. CAGR %	691.9	28.06	-40.54	-47.03	-37.98
Unlevered Free Cash Flow, 2 Yr. CAGR %	529.87	28.3	-35.96	-42.36	-37.29
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	53.67	36.99	-11.61	-5.79	3.31
Gross Profit, 3 Yr. CAGR %	78.13	54.59	-19.08	-10.21	2.56
EBITDA, 3 Yr. CAGR %	225.61	77.91	-40.07	-27.72	-17.87
EBITA, 3 Yr. CAGR %	338.82	85.85	-44.46	-31.03	-22.99
EBIT, 3 Yr. CAGR %	292.57	278.57	-50.02	-34.25	-29.67
Earnings From Cont. Operations, 3 Yr. CAGR %	179.66	99.24	-59.63	-59.58	-42
Net Income, 3 Yr. CAGR %	179.66	99.24	-59.63	-59.58	-42
Normalized Net Income, 3 Yr. CAGR %	207.58	260.1	-52.95	-41.16	-35.94
Diluted EPS Before Extra, 3 Yr. CAGR %	170.14	105.5	-59.62	-58.8	-40.21
Accounts Receivable, 3 Yr. CAGR %	75.18	20.7	-19.28	-9.89	0.24
Inventory, 3 Yr. CAGR %	20.84	34.53	18.39	18.22	9.76
Net Property, Plant and Equip., 3 Yr. CAGR %	23.64	17.81	7.44	8.31	-0.09
Total Assets, 3 Yr. CAGR %	44.27	59.83	22.45	7.01	-8.09
Tangible Book Value, 3 Yr. CAGR %	710.17	89.11	-12.88	-25.58	2.85
Common Equity, 3 Yr. CAGR %	75.78	67.87	17.55	3.6	2.07
Cash From Operations, 3 Yr. CAGR %	401.38	105.13	-21.31	-36.72	-24.08
Capital Expenditures, 3 Yr. CAGR %	4.3	21.2	20.85	20.8	64.3
Levered Free Cash Flow, 3 Yr. CAGR %	128.55	293.07	-15.72	-35.23	-48.02
Unlevered Free Cash Flow, 3 Yr. CAGR %	143.01	238.77	-11.69	-31.21	-45.2
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	46.12	29.01	20.67	21.11	-2.28
Gross Profit, 5 Yr. CAGR %	83.25	39.22	26.73	31.43	-6.67
EBITDA, 5 Yr. CAGR %	73.37	231.23	53.22	33.52	-23.95
EBITA, 5 Yr. CAGR %	67.72	103.3	75.62	34.82	-27.84
EBIT, 5 Yr. CAGR %	56.83	39.78	54.31	103.65	-33.28
Earnings From Cont. Operations, 5 Yr. CAGR %	50.92	20.13	11.8	4.86	-41.9
Net Income, 5 Yr. CAGR %	50.92	20.13	11.8	4.86	-41.9
Normalized Net Income, 5 Yr. CAGR %	57.52	35.37	28.48	85.46	-37.07
Diluted EPS Before Extra, 5 Yr. CAGR %	22.98	16.41	8.76	6.82	-40.92
Accounts Receivable, 5 Yr. CAGR %	53.87	32.75	26.98	11.48	-8.4
Inventory, 5 Yr. CAGR %	49.56	24.19	18.36	24.79	17.24
Net Property, Plant and Equip., 5 Yr. CAGR %	53.03	23.63	18.27	10.51	4.95
Total Assets, 5 Yr. CAGR %	45.77	35.81	35.25	25.99	8.3
Tangible Book Value, 5 Yr. CAGR %	131.55	106.48	190.84	47.95	-6.28
Common Equity, 5 Yr. CAGR %	67.45	40.42	42.69	37.37	11.27
Cash From Operations, 5 Yr. CAGR %	81.81	77.06	119.69	27.33	-19.26
Capital Expenditures, 5 Yr. CAGR %	55.99	-6.24	20.02	15.38	40.48
Levered Free Cash Flow, 5 Yr. CAGR %	110.8	59.04	33.38	76.32	-25.45
Unlevered Free Cash Flow, 5 Yr. CAGR %	117.48	62.84	42.54	66.81	-22.99